Biem Pharmaceuticals is primarily a speciality pharmaceutical marketing partner to commercialise later stage or marketed products in the territory of Turkey and select markets. We know that good partnerships are key to success. We are committed to continued and strategic growth through targeted product acquisitions, in-licensing new opportunities and forming mutually beneficial business partnerships.

At this stage, we are willing to look at all therapeutic areas with a strong focus on Biologicals, Oncology, Hematology, Ophtalmology, Radiology and Gynecology. While concentrating on speciality prescription pharmaceuticals, we will also consider acquiring generic pharmaceuticals.

We continue to identify such product opportunities and specialty areas that fit our capabilities and enhance our future business objectives. In our partnerships, Biem shares the desire to bring novel therapeutics to patients on a local and global basis.

We are seeking new products for acquisition, promotion, and/or in and outlicensing which are already on the market or in late-stage development. We work independently as well as in partnership with companies that share the same goal.

All of our contract manufacturers are GMP audited and certified by Turkish Medicines and Medical Devices Agency (TMMDA) who is PIC/S member since January 2018.

Our Contract Manufacturer Facilities hold EU GMP Certificates.


We create new opportunities for our collaborations with various business model. In this way, Biem is an active business partner in both domestic and overseas market.